Global Retirement Partners LLC Acquires 37,605 Shares of Healthpeak Properties, Inc. $DOC

Global Retirement Partners LLC boosted its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 502.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 45,086 shares of the real estate investment trust’s stock after purchasing an additional 37,605 shares during the period. Global Retirement Partners LLC’s holdings in Healthpeak Properties were worth $863,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Mather Group LLC. bought a new stake in shares of Healthpeak Properties during the third quarter worth $25,000. Rexford Capital Inc. acquired a new position in Healthpeak Properties during the 2nd quarter worth about $28,000. Sound Income Strategies LLC acquired a new position in Healthpeak Properties during the 3rd quarter worth about $28,000. Elevation Point Wealth Partners LLC bought a new stake in Healthpeak Properties during the 2nd quarter worth about $32,000. Finally, CYBER HORNET ETFs LLC acquired a new stake in Healthpeak Properties in the 2nd quarter valued at about $33,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Key Stories Impacting Healthpeak Properties

Here are the key news stories impacting Healthpeak Properties this week:

• Positive Sentiment: Healthpeak announced the formation of Janus Living, a pure‑play, RIDEA‑structured senior housing REIT and plans an IPO; Healthpeak will contribute a 34‑community, 10,422‑unit senior housing portfolio to the new vehicle — a move that can unlock asset value, create a clearer pure‑play senior housing story and potentially raise capital. BusinessWire: Formation of Janus Living SeniorHousingNews: Janus Living
• Positive Sentiment: Healthpeak confirmed a confidential submission of a draft registration statement (S‑1) for Janus Living — a formal step toward an IPO that provides a timeline and process visibility for investors assessing value realization from the contributed portfolio. Yahoo Finance: Confidential S-1 Submission
• Positive Sentiment: Healthpeak reiterated monthly dividend declarations (monthly payment of $0.1017 per share, implying ~7.4% yield on current levels) with upcoming record/ex‑dividend dates — supports income investors and can help support the share price while the corporate actions progress.
• Neutral Sentiment: Market commentary and analyst pieces are parsing whether recent DOC weakness presents a buying opportunity given the yield and repositioning; these are opinion pieces that may influence sentiment but not facts about the transaction. Yahoo Finance: Opportunity Analysis
• Negative Sentiment: Risks that could pressure DOC: the IPO could reduce Healthpeak’s scale/FFO contribution from the senior‑housing portfolio, create near‑term transaction costs or tax/structural complexity, and the success of Janus Living depends on market reception — any poor pricing or delayed IPO could weigh on DOC shares. BusinessWire: Transaction Details

Wall Street Analysts Forecast Growth

DOC has been the topic of a number of research reports. Jefferies Financial Group lowered shares of Healthpeak Properties from a “buy” rating to a “hold” rating and reduced their target price for the stock from $21.00 to $17.00 in a research report on Monday, December 15th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Healthpeak Properties in a report on Monday, December 29th. Robert W. Baird decreased their price objective on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 12th. Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a research note on Monday. Finally, Raymond James Financial raised Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a research note on Monday, September 15th. Six investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, Healthpeak Properties has a consensus rating of “Moderate Buy” and an average target price of $19.91.

Healthpeak Properties Price Performance

DOC opened at $16.95 on Thursday. The company has a fifty day moving average price of $17.07 and a two-hundred day moving average price of $17.71. The firm has a market capitalization of $11.78 billion, a PE ratio of -338.83, a P/E/G ratio of 4.17 and a beta of 1.12. Healthpeak Properties, Inc. has a 52 week low of $15.71 and a 52 week high of $21.28. The company has a debt-to-equity ratio of 1.11, a quick ratio of 1.22 and a current ratio of 1.22.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.01. Healthpeak Properties had a negative return on equity of 0.44% and a negative net margin of 1.36%.The business had revenue of $705.87 million for the quarter, compared to analyst estimates of $681.65 million. During the same period last year, the company earned $0.45 EPS. The firm’s revenue was up .8% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be issued a dividend of $0.1017 per share. The ex-dividend date is Tuesday, March 17th. This represents a c) dividend on an annualized basis and a yield of 7.2%. Healthpeak Properties’s dividend payout ratio (DPR) is -2,440.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.